Management of Hypertriglyceridemia in Patients with Liver Disease
Lifestyle Modifications
- The American Association for the Study of Liver Diseases recommends lifestyle modification as the cornerstone of treatment, targeting 7-10% weight loss through hypocaloric diet and exercise, with a goal of reducing triglycerides by 20-70% in some patients 1
- Carbohydrate restriction is more effective than fat restriction for reducing liver fat and triglycerides in NAFLD patients, with very low-carbohydrate ketogenic diets showing particular benefit, and the European Association for the Study of the Liver suggests restricting added sugars to <6% of total daily calories and limiting saturated fats to <7% of total calories 2
- Complete alcohol abstinence is mandatory, as all guidelines advise against any alcohol consumption in NAFLD patients despite potential metabolic benefits of light-moderate intake, according to the American College of Gastroenterology 1
- Engage in at least 150 minutes per week of moderate-intensity aerobic activity, as recommended by the American Heart Association 1, 2
Pharmacologic Considerations
- Statins can be used cautiously in patients with NAFLD, as 34.1% of general practitioners incorrectly believe statins should be avoided in NAFLD patients, though monitoring of liver enzymes is prudent, according to the European Association for the Study of the Liver 1
- Prescription omega-3 fatty acids (2-4g daily) represent a safer alternative to fenofibrate, as they reduced triglycerides by 26% without increasing liver fat in NAFLD patients, and are recommended by the National Lipid Association 2
- If LDL-C is elevated and cardiovascular risk is high, statins are the preferred first-line agent, providing 10-30% triglyceride reduction, as recommended by the American College of Cardiology 2
Monitoring Strategy
- Recheck fasting lipid panel in 4-8 weeks after initiating lifestyle modifications, and monitor liver function tests (ALT, AST, bilirubin) at baseline and every 3 months until stable, then annually in patients with known liver disease, as recommended by the American Association for the Study of Liver Diseases 2, 4
- Reassess for secondary causes (thyroid function, HbA1c, renal function) if triglycerides fail to improve, according to the European Association for the Study of the Liver 3, 4